Steward Partners Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.02M Sell
22,238
-10,925
-33% -$4.43M 0.07% 275
2025
Q1
$16.5M Buy
33,163
+414
+1% +$206K 0.15% 143
2024
Q4
$17M Sell
32,749
-1,145
-3% -$596K 0.15% 132
2024
Q3
$21M Buy
33,894
+271
+0.8% +$168K 0.19% 111
2024
Q2
$18.6M Buy
33,623
+341
+1% +$189K 0.2% 104
2024
Q1
$19.3M Buy
33,282
+1,556
+5% +$904K 0.21% 96
2023
Q4
$16.8M Sell
31,726
-1,005
-3% -$533K 0.23% 89
2023
Q3
$16.6M Buy
32,731
+729
+2% +$369K 0.25% 85
2023
Q2
$16.7M Sell
32,002
-401
-1% -$209K 0.25% 88
2023
Q1
$18.7M Sell
32,403
-909
-3% -$524K 0.3% 77
2022
Q4
$18.3M Buy
33,312
+3,165
+10% +$1.74M 0.31% 74
2022
Q3
$15.3M Sell
30,147
-999
-3% -$507K 0.29% 77
2022
Q2
$16.9M Sell
31,146
-1,623
-5% -$882K 0.31% 75
2022
Q1
$19.4M Buy
32,769
+792
+2% +$468K 0.3% 73
2021
Q4
$21.3M Buy
31,977
+8,914
+39% +$5.95M 0.32% 67
2021
Q3
$13.2M Sell
23,063
-1,759
-7% -$1.01M 0.23% 104
2021
Q2
$12.5M Sell
24,822
-3,415
-12% -$1.72M 0.21% 106
2021
Q1
$12.9M Buy
28,237
+2,532
+10% +$1.16M 0.23% 105
2020
Q4
$12M Buy
25,705
+1,106
+4% +$515K 0.26% 99
2020
Q3
$10.9M Buy
24,599
+8,714
+55% +$3.85M 0.27% 89
2020
Q2
$5.76M Sell
15,885
-4,061
-20% -$1.47M 0.16% 151
2020
Q1
$5.66M Sell
19,946
-3,109
-13% -$882K 0.21% 120
2019
Q4
$7.49M Buy
23,055
+1,075
+5% +$349K 0.22% 108
2019
Q3
$6.4M Buy
21,980
+3,346
+18% +$975K 0.22% 113
2019
Q2
$5.47M Buy
18,634
+2,186
+13% +$642K 0.2% 121
2019
Q1
$4.5M Sell
16,448
-3,404
-17% -$932K 0.19% 123
2018
Q4
$4.44M Buy
19,852
+2,377
+14% +$532K 0.22% 112
2018
Q3
$4.27M Sell
17,475
-9,735
-36% -$2.38M 0.2% 119
2018
Q2
$5.64M Buy
27,210
+1,284
+5% +$266K 0.34% 71
2018
Q1
$5.35M Buy
25,926
+1,524
+6% +$315K 0.37% 62
2017
Q4
$4.63M Buy
24,402
+15,763
+182% +$2.99M 0.35% 69
2017
Q3
$1.63M Sell
8,639
-255
-3% -$48.2K 0.17% 132
2017
Q2
$1.55M Buy
8,894
+10
+0.1% +$1.74K 0.17% 131
2017
Q1
$1.36M Buy
8,884
+4,383
+97% +$673K 0.21% 105
2016
Q4
$635K Buy
+4,501
New +$635K 0.29% 84